Ahrum Min

1.4k total citations
36 papers, 957 citations indexed

About

Ahrum Min is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ahrum Min has authored 36 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 22 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ahrum Min's work include PARP inhibition in cancer therapy (14 papers), DNA Repair Mechanisms (13 papers) and Advanced Breast Cancer Therapies (5 papers). Ahrum Min is often cited by papers focused on PARP inhibition in cancer therapy (14 papers), DNA Repair Mechanisms (13 papers) and Advanced Breast Cancer Therapies (5 papers). Ahrum Min collaborates with scholars based in South Korea, United States and United Kingdom. Ahrum Min's co-authors include Seock‐Ah Im, Seock Ah Im, Do‐Youn Oh, Yung‐Jue Bang, Tae‐Yong Kim, Mark J. O’Connor, Kyung-Hun Lee, Sae‐Won Han, Seongyeong Kim and Hee Jun Kim and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Ahrum Min

36 papers receiving 952 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ahrum Min South Korea	16	635	634	181	123	78	36	957
Jessica Frankum United Kingdom	14	697 1.1×	843 1.3×	125 0.7×	184 1.5×	52 0.7×	21	1.1k
François Ringeisen France	14	373 0.6×	517 0.8×	305 1.7×	175 1.4×	57 0.7×	33	899
Allison Landman United States	9	449 0.7×	700 1.1×	187 1.0×	193 1.6×	72 0.9×	15	955
Mónica Musteanu Spain	14	552 0.9×	415 0.7×	149 0.8×	181 1.5×	76 1.0×	32	972
Aimee Bence Lin United States	18	636 1.0×	622 1.0×	259 1.4×	144 1.2×	66 0.8×	42	977
María Luisa Botero United States	5	322 0.5×	538 0.8×	176 1.0×	204 1.7×	129 1.7×	11	844
Paul M. Moseley United Kingdom	22	616 1.0×	796 1.3×	116 0.6×	314 2.6×	112 1.4×	45	1.1k
Susann Weissmueller United States	5	414 0.7×	725 1.1×	119 0.7×	250 2.0×	70 0.9×	6	992
Elizabeth Ruth Plummer United Kingdom	19	961 1.5×	836 1.3×	116 0.6×	181 1.5×	64 0.8×	69	1.3k
Tammie C. Yeh United States	11	503 0.8×	614 1.0×	234 1.3×	75 0.6×	115 1.5×	21	1.0k

Countries citing papers authored by Ahrum Min

Since Specialization

Citations

This map shows the geographic impact of Ahrum Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahrum Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahrum Min more than expected).

Fields of papers citing papers by Ahrum Min

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahrum Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahrum Min. The network helps show where Ahrum Min may publish in the future.

Co-authorship network of co-authors of Ahrum Min

This figure shows the co-authorship network connecting the top 25 collaborators of Ahrum Min. A scholar is included among the top collaborators of Ahrum Min based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahrum Min. Ahrum Min is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Min, Ahrum, et al.. (2025). Elimusertib, a Novel ATR Inhibitor, Induces Anti-tumor Effects through Replication Catastrophe in Breast Cancers. Cancer Research and Treatment. 58(1). 159–174. 1 indexed citations

Kim, So Hyeon, Young Joo Park, Ahrum Min, et al.. (2025). DNA damage and Nuclear Anaplasia Induced by Trastuzumab Deruxtecan in Cancer Cells with Variable HER2 Expression and Homologous Recombination Deficiency Status. Cancer Research and Treatment. 1 indexed citations

Park, Jae Hyeon, Kyung-Hun Lee, Jiwon Koh, et al.. (2025). Establishment and characterization of 24 breast cancer cell lines and 3 breast cancer organoids reveals molecular heterogeneity and drug response variability in malignant pleural effusion-derived models. Breast Cancer Research. 27(1). 66–66. 1 indexed citations

Park, Yeon Hee, Seock‐Ah Im, Kyunghee Park, et al.. (2021). Prospective longitudinal multi-omics study of palbociclib resistance in hormone receptor+/HER2- metastatic breast cancer.. Journal of Clinical Oncology. 39(15_suppl). 1013–1013. 8 indexed citations

Yang, Yaewon, Ahrum Min, Kyung-Hun Lee, et al.. (2020). Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients. Journal of Breast Cancer. 23(2). 182–182. 9 indexed citations

Min, Ahrum, Seongyeong Kim, Hyemin Jang, et al.. (2020). Antitumor effect of a WEE1 inhibitor and potentiation of olaparib sensitivity by DNA damage response modulation in triple-negative breast cancer. Scientific Reports. 10(1). 9930–9930. 56 indexed citations

Kim, Jung Youn, Dae‐Won Lee, Kyung-Hun Lee, et al.. (2019). Prognostic role of body mass index is different according to menopausal status and tumor subtype in breast cancer patients. Breast Cancer Research and Treatment. 176(2). 453–460. 7 indexed citations

Min, Ahrum, Hyemin Jang, Seongyeong Kim, et al.. (2018). Androgen Receptor Inhibitor Enhances the Antitumor Effect of PARP Inhibitor in Breast Cancer Cells by Modulating DNA Damage Response. Molecular Cancer Therapeutics. 17(12). 2507–2518. 15 indexed citations

Min, Ahrum, Jung Eun Kim, Yu‐Jin Kim, et al.. (2018). Cyclin E overexpression confers resistance to the CDK4/6 specific inhibitor palbociclib in gastric cancer cells. Cancer Letters. 430. 123–132. 55 indexed citations

10.

Kang, Han Na, Hyunwoo Kim, Ahrum Min, et al.. (2018). Profiling of protein–protein interactions via single-molecule techniques predicts the dependence of cancers on growth-factor receptors. Nature Biomedical Engineering. 2(4). 239–253. 23 indexed citations

11.

Min, Ahrum, Seock‐Ah Im, Hyemin Jang, et al.. (2017). AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells. Molecular Cancer Therapeutics. 16(4). 566–577. 105 indexed citations

12.

Kim, Hee‐Jun, Ahrum Min, Seock‐Ah Im, et al.. (2016). Anti‐tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells. International Journal of Cancer. 140(1). 109–119. 49 indexed citations

13.

Suh, Koung Jin, Han Suk Ryu, Kyung-Hun Lee, et al.. (2016). Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer. Breast Cancer Research and Treatment. 158(2). 233–241. 13 indexed citations

14.

Kim, Seongyeong, Ahrum Min, Kyung-Hun Lee, et al.. (2016). Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis. Cancer Research and Treatment. 49(3). 643–655. 26 indexed citations

15.

Kim, Ji‐Won, Ahrum Min, Kyung-Hun Lee, et al.. (2015). Amphiregulin confers trastuzumab resistance via AKT and ERK activation in HER2-positive breast cancer. Journal of Cancer Research and Clinical Oncology. 142(1). 157–165. 36 indexed citations

16.

Min, Ahrum, Seock‐Ah Im, Sang-Hyun Song, et al.. (2015). Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells. Breast Cancer Research. 17(1). 33–33. 143 indexed citations

17.

Kim, Hyori, Jeonghwan Youk, Yaewon Yang, et al.. (2015). Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy. Journal of Cancer Research and Clinical Oncology. 142(3). 707–714. 7 indexed citations

18.

Min, Ahrum, Seock‐Ah Im, Young‐Kwang Yoon, et al.. (2013). RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib. Molecular Cancer Therapeutics. 12(6). 865–877. 109 indexed citations

19.

Im, Seock‐Ah, Do‐Youn Oh, Paul Elvin, et al.. (2012). Antitumor Activity of Saracatinib (AZD0530), a c-Src/Abl Kinase Inhibitor, Alone or in Combination with Chemotherapeutic Agents in Gastric Cancer. Molecular Cancer Therapeutics. 12(1). 16–26. 50 indexed citations

20.

Min, Ahrum, Seock‐Ah Im, Sang-Hyun Song, et al.. (1970). TGF-β Suppresses COX-2 Expression by Tristetraprolin-Mediated RNA Destabilization in A549 Human Lung Cancer Cells. Cancer Research and Treatment. 47(1). 101–109. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact